marie@mpmcapital.com, Author at MPM BioImpact | Page 3 of 3

2nd August 2023

Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement

11th May 2023

Post-Pandemic Healthcare Investing — Chris Bardon on CNBC’s “The Exchange”

27th April 2023

Antiva Biosciences Closes $53 Million Series E Equity Financing

13th April 2023

GBR Connect Series – Interview with Chris Bardon

1 2 3